In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Pallone's Push For Cosmetics Reform Falls Flat During OTC Monograph Bill Markup

This article is powered by The Rose Sheet

Executive Summary

The New Jersey Democrat introduced multiple cosmetics-related amendments during the House Health Subcommittee's markup of draft OTC monograph reform legislation. While ultimately nothing came of the proposed measures, it's clear that Pallone remains intent on updating cosmetics regulations to require facility registration, adverse event reporting and good manufacturing practices, among other aims.

Advertisement

Related Content

Elections Reshape Congress But Not Supplement Industry Regulatory Outlook
Congressional Races Could Alter Cosmetics Legislative Outlook, Starting With House Energy & Commerce
OTC Monograph Legislation Clears Another Hurdle Despite Exclusivity Concerns
OTC Monograph Reform Momentum Carries Potential Exclusivity Snag
Surprise Hatch Bill Lays Middle Ground For Cosmetic Regulatory Reform
Rep. Pallone Seeks Answers In Tween Makeup Asbestos Controversy
Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners
PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises
Senate HELP Hearing Focuses On WEN, High-Profile Cosmetic Safety Issues
Pallone Proposes House Companion To PCPSA; Will 2017 Be The Year For Reform?

Topics

Advertisement
UsernamePublicRestriction

Register

RS121420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel